Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1869105 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $8.59Day −1.83%Mkt cap $688MOff 52W high −42.2%Vol (1Y) 71.2%
Daily closing price, split-adjusted to the current basis; 0.9y shown of 231 bars on file. Sampled to 231 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest7.1% of sh out |
| Days to cover12.6d |
| 13F net flow (QoQ)−2.57% |
| Top-10 13F concentration76.5% |
| Next report (est.)2026-08-11 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$154.1M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−31.4% |
Total return through 2026-07-28 · series begins 2025-08-12. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)71.2% |
| Ann. volatility (3Y)71.2% |
| Sharpe (1Y)0.18 |
| Sharpe (3Y)0.18 |
| Max drawdown (1Y)−48.1% |
| Max drawdown (3Y)−48.1% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 17.9M | $160M | 22.32% | +0.0% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4.9M | $44M | 6.10% | +0.0% |
| Omega Fund Management, LLC | 3.3M | $29M | 4.11% | +0.0% |
| EcoR1 Capital, LLC | 2.8M | $25M | 3.52% | +0.0% |
| Alphabet Inc. | 2.8M | $25M | 3.52% | +0.0% |
| WELLINGTON MANAGEMENT GROUP LLP | 2.8M | $25M | 3.52% | −3.0% |
| ENAVATE SCIENCES GP, LLC | 2.6M | $24M | 3.28% | +0.0% |
| CITADEL ADVISORS LLC | 2.5M | $23M | 3.16% | −0.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$526.11 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$1.03 | — | — | — |
| 2025-03-31 | 2025-05-15 | −$54.23 | — | — | — |
| 2024-09-30 | 2024-11-14 | −$1,562.18 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-11 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
